Categories AlphaGraphs, Analysis, Retail

Home Depot beats Q3 estimates; updates full-year outlook

Home Depot’s (HD) stock rose 3.3% in premarket trade on Tuesday after the company beat market estimates on revenue and earnings for the third quarter of 2018 and updated its guidance for the full year.

Total sales grew 5.1% year-over-year to $26.3 billion compared to the same period last year. Comparable sales grew 4.8% globally and 5.4% in the US. Net income improved to $2.9 billion, or $2.51 per share, from $2.2 billion, or $1.84 per share, last year.

Home Depot third quarter 2018 Earnings Infographic
Home Depot Q3 2018 Earnings Infographic

During the quarter, customer transactions improved 1.4% while average ticket grew 3.6%. Sales per square foot saw a growth of 5.2% during the period compared to last year.

Home Depot saw growth in both professional and do-it-yourself (DIY) customers during the quarter. The initiatives undertaken to expand assortment and improve the shopping experience helped drive strong performance across stores. The company also saw good growth in its digital business.

Based on its year-to-date performance, Home Depot updated its guidance for the full year of 2018. The company will have 53 weeks of operating results in 2018 and now expects sales growth of around 7.2% compared to the previous outlook of 7%.

Comp sales is expected to grow around 5.5% for the comparable 52-week period versus the previous guidance of 5.3%. The company now expects EPS to grow about 33.8% to $9.75. The earlier projection was for a growth of 29.2% in EPS to $9.42.

Home Depot’s competitor Lowe’s Companies (LOW) is scheduled to report third quarter 2018 results on November 20.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top